SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-072615
Filing Date
2015-09-30
Accepted
2015-09-30 19:21:43
Documents
1
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5161
  Complete submission text file 0001209191-15-072615.txt   6501
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744 512-681-5252
Mirna Therapeutics, Inc. (Issuer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5425 WISCONSIN AVENUE, SUITE 800 CHEVY CHASE MD 20815
Business Address
Florence Anthony A. Jr. (Reporting) CIK: 0001559827 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37566 | Film No.: 151134979